tiprankstipranks

Kimberly Blackwell Insider Profile

4 Followers
Kimberly Blackwell, CEO, Director at Zentalis Pharmaceuticals, holds 484.14K shares in Zentalis Pharmaceuticals (Ticker: ZNTL), holds ― shares in Century Therapeutics (Ticker: IPSC), holds ― shares in Monte Rosa Therapeutics (Ticker: GLUE).
tipranks
Kimberly Blackwell

Kimberly Blackwell
Zentalis Pharmaceuticals (ZNTL)
CEO, Director

Not Ranked
Kimberly Blackwell has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$6M
100.00%
0.00%
0.00%
A breakdown of Kimberly Blackwell's holdings

Insider Roles

Zentalis Pharmaceuticals
(ZNTL)
CEO, Director
Century Therapeutics
(IPSC)
Director
Monte Rosa Therapeutics
(GLUE)
Director
Roles that Kimberly Blackwell holds in companies

Most Profitable Insider Trade

Stock:
Zentalis Pharmaceuticals
(ZNTL)
Rating:Informative Buy
Date:Nov 13, 2023 - Today
Return:+14.10%
The most profitable trade made by Kimberly Blackwell

Kimberly Blackwell's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Zentalis Pharmaceuticals
Feb 05, 2024
CEO, Director
Uninformative Buy
$5.96M
Century Therapeutics
Director
Monte Rosa Therapeutics
Director
List of latest transactions for each holding click on a transaction to see Kimberly Blackwell's performance on stock

Kimberly Blackwell insider profile FAQ

What is the percentage of profitable transactions made by Kimberly Blackwell?
The percentage of profitable transactions made by Kimberly Blackwell is ―.
    What is the average return per transaction made by Kimberly Blackwell?
    The average return per transaction made by Kimberly Blackwell is ―.
      What stocks does Kimberly Blackwell hold?
      Kimberly Blackwell holds: ZNTL, IPSC, GLUE stocks.
        What was Kimberly Blackwell’s latest transaction?
        Kimberly Blackwell latest transaction was an Uninformative Buy of ―.
          What was Kimberly Blackwell's most profitable transaction?
          Kimberly Blackwell’s most profitable transaction was an Informative Buy of ZNTL stock on November 13, 2023. The return on the trade was 14.10%.
            What is Kimberly Blackwell's role in Zentalis Pharmaceuticals?
            Kimberly Blackwell's role in Zentalis Pharmaceuticals is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.